Hypersensitivity to Biologics Used in the Treatment of Inflammatory Disorders: Allergy Interventions and Outcomes

Clinical & Experimental Allergy 2026 Open access

Read full text
Authors: Trine Holm Rasmussen, Charlotte Gotthard Mortz, Line Kring Tannert, Carsten Bindslev‐Jensen
DOI: 10.1111/cea.70210
Cited by: 1
References: 9

Abstract

Summary Allergy evaluations are important for delabeling non‐hypersensitive patients and diagnosing and treating concomitant skin conditions. Rapid drug desensitisation enables patients to continue treatment with critical biologics, but treatment is complicated.

Fields of Study & Subjects

Drug-Induced Adverse Reactions Contact Dermatitis and Allergies Dermatology and Skin Diseases

Publication details

Journal / source
Clinical & Experimental Allergy
Publisher
Wiley
Volume
56
Issue
4
Pages
442–445
Publication date
5 January 2026
Language
EN